Care and treatment support

A strong focus on innovation & adherence

Interruption of TB treatment leads to poor treatment outcomes, resistant forms of TB and continuous transmission in the community. It is one of the major challenges facing TB eradication today. Traditionally, countries strictly employed health facility based Directly Observed Treatment (DOT), but this resource-straining approach has become outdated. New digital tools can enhance existing processes and employ a more patient-centered, data-driven approach. Scalable and affordable “digital adherence technologies” like Medication Event Monitor Systems (MEMS), the 99DOTS solution, and Video Supported Therapy (VOT) are acceptable to patients and providers, can inform approaches to differentiate care and guide overall case management, leading to improvement in treatment outcomes. To support the appropriate design and implementation of these adherence technologies, KNCV is working with partners to demonstrate these technologies in-country and develop an implementation package to guide global scale-up of these innovative digital solutions.

99DOTS: Low-cost innovation to empower patients

Pairing innovations in medication packaging with mobile phone technology, 99DOTS is an mHealth system that empowers patients to accurately report their daily treatment log their daily treatment adherence from the comfort of their own home. TB medication blister packs are repackaged in a low-cost, custom cardstock sleeve with a series of unpredictable hidden toll-free phone numbers that are revealed each time a patient takes their daily pill dose. The patient calls or texts (SMS) this number and their daily adherence is automatically logged on a secure dashboard accessible to their health care provider. This enables health care workers to target resources to patients most in need of support and also provides accurate, real-time adherence data to national programs for analysis and creation of improved patient approaches.

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.